Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-003499
Filing Date
2025-01-08
Accepted
2025-01-08 16:53:05
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11238
  Complete submission text file 0000950170-25-003499.txt   12653
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Issuer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Miller Deborah Ann (Reporting) CIK: 0001868741 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40671 | Film No.: 25519126